• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOYA SURGICAL OPTICS, INC. HOYA ISERT 251; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOYA SURGICAL OPTICS, INC. HOYA ISERT 251; INTRAOCULAR LENS Back to Search Results
Model Number ISERT 251 (+23.50 D)
Medical Device Problem Code Appropriate Device Problem Term/Code Not Available (3191)
Health Effect - Clinical Code Visual Disturbances (2140)
Date of Event 11/08/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This initial emdr is being submitted to fda for outside us like products reporting."lens surface reflection" is indicated as a potential malfunction in hoya ifu covered under the warnings section.Manufacturer's codes for patient health effects (clinical and impact), and device problem and component have been entered in this report.Manufacturer's codes for investigation type, findings and conclusion are pending the completion of the product investigation.Once the investigation is completed, an follow-up report will be submitted to fda which will include the manufacturer's codes for investigation type, findings and conclusion.
 
Event or Problem Description
Implant date: (b)(6) 2020.Flawed optic: optic surface reflection; patient sees the halo effect on the periphery of the optic.Post-operative complications; within 5 days after implantation no inflammation.Lens remains implanted.
 
Additional Manufacturer Narrative
This follow-up #1 emdr is being submitted to fda for a reportable adverse event that occurred outside of the usa.The report includes additional information not available/included in the initial report.Additional information: g6 - type of report - noted as follow-up #1.H2 - type of follow-up - noted for additional information.H3 - device evaluated - noted that device was not returned.H6 - added codes for manufacturer's investigation: type; findings; and conclusion.The investigation was conducted, with the methods and results as noted below.The product was not returned.No abnormalities were found in production and inspection records of the product.(serial no.: (b)(6); model: 251).The exact root cause was not determined.However, we believe this event was not caused by our product quality.Risk analysis was conducted on the product line and failure code is noted below.A review of the most recent complaint trending data indicates that no significant trends have been identified at this time and no capa is required as part of the product evaluation.
 
Event or Problem Description
Implant date: (b)(6) 2020.Flawed optic: optic surface reflection; patient sees the halo effect on the periphery of the optic.Post-operative complications; within 5 days after implantation.No inflammation.Lens remains implanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HOYA ISERT 251
Common Device Name
INTRAOCULAR LENS
Manufacturer (Section D)
HOYA SURGICAL OPTICS, INC.
15335 fairfield ranch rd.
suite 250
chino hills CA 91709
MDR Report Key11335633
Report Number3006723646-2021-00007
Device Sequence Number16812206
Product Code HQL
UDI-Device Identifier04547480450360
UDI-Public04547480450360
Combination Product (Y/N)N
Initial Reporter CountryPL
PMA/510(K) Number
P080004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 01/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date05/31/2022
Device Model NumberISERT 251 (+23.50 D)
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 01/19/2021
Supplement Date Received by Manufacturer01/19/2021
Initial Report FDA Received Date02/16/2021
Supplement Report FDA Received Date03/23/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
-
-